(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

XENPROT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

XENPROT

ST13

US500000098925213

Class

42

Filing

98925213

Registration

8000589

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

01/01/2026

Trademark type

Combined

Nice classes

42

Filing date

12/27/2024

Registration date

10/28/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/28/2025

Last transaction

01/01/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

5

Owner type

99

Owner location

SHANGHAI, CN

Examiner

NELMAN,JESSE M

Law office

O20

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of stylized letters "XENPROT".

Holders and representatives

Holders

SHANGHAI AILUX BIOTECHNOLOGY CO., LTD.
Jingtai Zhiyao Technology (Shanghai) Co., Ltd.

Representatives

Alex Patel Patel IP, P.C.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Biochemical research and analysis; Conducting early evaluations in the field of new pharmaceuticals; Design of computer-simulated models; DNA screening for scientific research purposes; Pharmaceutical research and development; Platform as a service (PAAS) featuring computer software platforms for scientific researchsoftware for analyzing scientific and medical data that is necessary for pharmaceutical drug development and antibody development; Research and development of new products for others; Research and development services in the field of antibodies; Research in the field of artificial intelligence; Software as a service (SAAS) services featuring software for scientific researchsoftware for analyzing scientific and medical data that is necessary for pharmaceutical drug development and antibody development

Publications

History of USPTO decisions and trademark events.

26 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

12/31/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/28/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

10/28/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/27/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/27/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/27/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/09/2025

PUBO

PUBLISHED FOR OPPOSITION

09/09/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/03/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/11/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/11/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/11/2025

ALIE

ASSIGNED TO LIE

08/07/2025

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

08/04/2025

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

04/01/2025

GNSL

LETTER OF SUSPENSION E-MAILED

04/01/2025

CNSL

SUSPENSION LETTER WRITTEN

04/01/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/26/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/26/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/26/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/30/2025

GNRT

NON-FINAL ACTION E-MAILED

01/30/2025

CNRT

NON-FINAL ACTION WRITTEN

01/30/2025

DOCK

ASSIGNED TO EXAMINER

01/30/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/29/2025

NWAP

NEW APPLICATION ENTERED

12/27/2024

Continuous trademark protection

Get notified about every new filing that threatens XENPROT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.